報告摘要

Implantable Port Market Research Report By Material Type (Silicone, Polyurethane, Titanium), By Application (Chemotherapy, Antibiotic Therapy, Total Parenteral Nutrition, Blood Transfusion), By Insertion Method (Surgical Insertion, Percutaneous Insertion) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) Forecast to 2035 Overview of the Market According to MRFR research, the Implantable Port Market Size was projected at 2024 USD 3,290.28 Million. The Implantable Port Market Industry is projected to develop at a CAGR (growth rate) of 6.21% over the forecast period (2025 - 2035). Rising prevalence of chronic diseases drive the Implantable Port Market, which in turn increases the need for long-term intravenous access options. Implantable ports are becoming more popular as healthcare practitioners concentrate on improving patient comfort and treatment efficacy. Outpatient and home healthcare environments are expanding, which also drives demand as these facilities need consistent, efficient ways to deliver medication. Improvements in medical technology also guarantee safer, more durable implants, hence driving market expansion even more. Market possibilities include the creation of materials encouraging biocompatibility and reducing infection risk, therefore opening the path for more creative implantable port designs. Increasing patient-centric care focus opens up possibilities for including digital health technologies—such as remote monitoring systems—to enhance patient management. Increasing knowledge among healthcare professionals about the advantages of implantable ports can help to boost market penetration as well, particularly in underdeveloped areas where such technology is still being accepted. Recent trends show a move toward minimally invasive treatments, which would make implantable ports more appealing to both patients and doctors. Manufacturers and doctors working together are more common as they seek to enhance the design and use of these gadgets. Insights on Market Segments The worldwide implanted port market has been divided into silicone, polyurethane, and titanium depending on material kind. The global implantable port market has been divided into chemotherapy, antibiotic therapy, complete parenteral nutrition, and blood transfusion depending on application. The worldwide implantable port market has been divided into surgical insertion and percutaneous insertion depending on insertion technique. The fastest expanding sector during the forecast period, the surgical insertion segment had the largest market in 2024. Regional Knowledge The worldwide implantable port market has been divided into North America, Europe, Asia-Pacific, South America, and the Middle East & Africa depending on the area. In 2024, North America had the biggest market share and is projected to reach USD 2,416.61 million by 2035. On the other hand, Asia-Pacific is expected to expand at the fastest CAGR of 8.32% throughout the forecast period. With a predicted CAGR of 5.20% throughout the forecast period, the North America implantable port market made USD 1,382.75 million in 2024. North America is also divided into the US and Canada. With a predicted CAGR of 6.41% throughout the projection period, the Europe implantable port market was USD 972.35 million in 2024. Europe is divided more into Rest of Europe, Russia, Spain, Italy, France, UK, and Germany. Key Players Major Companies in the Implantable Port Market Include Easton Medical, Baxter International, Zyga Technology, Terumo, Apex Medical Technologies, Medtronic, Boston Scientific, Cook Medical, AngioDynamics, Kirwan Surgical Products, Smiths Medical, Nitinol Devices Corporation, C R Bard, Stryker, and Halyard Health.

目錄 Table of Contents

TABLE OF CONTENTS 1 EXECUTIVE SUMMARY ............................................................................................................... 19 1.1 OVERVIEW .................................................................................................................................................................... 19 1.2 MARKET ATTRACTIVENESS ANALYSIS ........................................................................................................... 20 1.3 GLOBAL IMPLANTABLE PORT MARKET, BY MATERIAL TYPE ................................................................ 21 1.4 GLOBAL IMPLANTABLE PORT MARKET, BY APPLICATION ...................................................................... 22 1.5 GLOBAL IMPLANTABLE PORT MARKET, BY END USER .............................................................................. 23 1.6 GLOBAL IMPLANTABLE PORT MARKET, BY INSERTION METHOD ........................................................ 24 1.7 GLOBAL IMPLANTABLE PORT MARKET, BY REGION ................................................................................... 25 2 MARKET INTRODUCTION ............................................................................................................ 27 2.1 DEFINITION .................................................................................................................................................................. 27 2.2 SCOPE OF THE STUDY .............................................................................................................................................. 27 2.3 RESEARCH OBJECTIVE ............................................................................................................................................ 27 2.4 MARKET STRUCTURE .............................................................................................................................................. 27 3 RESEARCH METHODOLOGY ...................................................................................................... 28 3.1 OVERVIEW .................................................................................................................................................................... 28 3.2 DATA FLOW .................................................................................................................................................................. 30 3.2.1 Data Mining Process ....................................................................................................................................... 30 3.3 PURCHASED DATABASE: ......................................................................................................................................... 31 3.4 SECONDARY SOURCES: ............................................................................................................................................ 32 3.4.1 Secondary Research Data Flow: ....................................................................................................................... 33 3.5 PRIMARY RESEARCH: ............................................................................................................................................... 34 3.5.1 Primary Research Data Flow: .......................................................................................................................... 35 3.5.2 Primary Research: Number of Interviews conducted ........................................................................................ 36 3.5.3 Primary Research: Regional Coverage ............................................................................................................. 36 3.6 APPROACHES FOR MARKET SIZE ESTIMATION: ........................................................................................... 37 3.6.1 Revenue Analysis Approach ............................................................................................................................ 37 3.7 DATA FORECASTING................................................................................................................................................. 38 3.7.1 Data forecasting Type ..................................................................................................................................... 38 3.8 DATA MODELING ........................................................................................................................................................ 39 3.8.1 Microeconomic Factor Analysis: ...................................................................................................................... 39 3.8.2 Data modeling: ............................................................................................................................................... 40 3.9 TEAMS AND ANALYST CONTRIBUTION ........................................................................................................... 42 4 MARKET DYNAMICS .................................................................................................................... 44 4.1 INTRODUCTION ........................................................................................................................................................... 44 4.2 DRIVERS ......................................................................................................................................................................... 44 4.2.1 Increasing Incidences of Chronic Diseases across the globe............................................................................. 44 4.2.2 Technological Advancements .......................................................................................................................... 45 4.2.3 Better Healthcare Access ................................................................................................................................ 46 4.3 RESTRAINTS ................................................................................................................................................................ 47 4.3.1 High Cost of Implantation ............................................................................................................................... 47 4.3.2 Surgical Risks ................................................................................................................................................. 47 4.4 OPPORTUNITY ............................................................................................................................................................. 48 4.4.1 Expansion in Emerging Markets ....................................................................................................................... 48 4.4.2 Growing Aging Population ............................................................................................................................... 48 5 MARKET FACTOR ANALYSIS ...................................................................................................... 49 5.1 VALUE CHAIN ANALYSIS ....................................................................................................................................... 49 5.1.1 R&D ............................................................................................................................................................... 49 5.1.2 Manufacturing ................................................................................................................................................ 49 5.1.3 Marketing and Distribution & Channel .............................................................................................................. 49 5.1.4 Post-market Surveillance ................................................................................................................................ 50 5.2 PORTER'S FIVE FORCES MODEL ........................................................................................................................... 50 5.2.1 Threat of New Entrants ................................................................................................................................... 51 5.2.2 Bargaining Power of Suppliers ......................................................................................................................... 51 5.2.3 Threat of Substitutes ...................................................................................................................................... 52 5.2.4 Bargaining Power of Buyers ............................................................................................................................ 52 5.2.5 Intensity of Rivalry .......................................................................................................................................... 52 5.3 IMPACT OF COVID-19 ON THE GLOBAL IMPLANTABLE PORT MARKET ............................................... 53 6 GLOBAL IMPLANTABLE PORT MARKET, BY MATERIAL TYPE ................................................. 55 6.1 OVERVIEW .................................................................................................................................................................... 55 6.2 SILICONE ........................................................................................................................................................................ 57 6.3 POLYURETHANE ........................................................................................................................................................ 58 6.4 TITANIUM ..................................................................................................................................................................... 58 7 GLOBAL IMPLANTABLE PORT MARKET, BY APPLICATION ...................................................... 59 7.1 OVERVIEW .................................................................................................................................................................... 59 7.2 CHEMOTHERAPY ....................................................................................................................................................... 61 7.3 ANTIBIOTIC THERAPY ............................................................................................................................................. 62 7.4 TOTAL PARENTERAL NUTRITION ...................................................................................................................... 62 7.5 BLOOD TRANSFUSION .............................................................................................................................................. 63 8 GLOBAL IMPLANTABLE PORT MARKET, BY END USER ........................................................... 64 8.1 OVERVIEW .................................................................................................................................................................... 64 8.2 HOSPITALS ................................................................................................................................................................... 66 8.3 AMBULATORY SURGICAL CENTERS ................................................................................................................... 67 8.4 SPECIALIZED CLINICS ............................................................................................................................................... 67 9 GLOBAL IMPLANTABLE PORT MARKET, BY INSERTION METHOD ......................................... 68 9.1 OVERVIEW .................................................................................................................................................................... 68 9.2 SURGICAL INSERTION .............................................................................................................................................. 70 9.3 PERCUTANEOUS INSERTION ................................................................................................................................. 71 10 GLOBAL IMPLANTABLE PORT MARKET, BY REGION ............................................................... 72 10.1 OVERVIEW .................................................................................................................................................................... 72 10.2 NORTH AMERICA ....................................................................................................................................................... 74 10.2.1 US.................................................................................................................................................................. 77 10.2.2 CANADA ........................................................................................................................................................ 78 10.3 EUROPE .......................................................................................................................................................................... 80 10.3.1 GERMANY ...................................................................................................................................................... 83 10.3.2 FRANCE ......................................................................................................................................................... 84 10.3.3 UK ................................................................................................................................................................. 86 10.3.4 ITALY ............................................................................................................................................................. 88 10.3.5 SPAIN ............................................................................................................................................................ 90 10.3.6 RUSSIA .......................................................................................................................................................... 92 10.3.7 REST OF EUROPE ............................................................................................................................................ 94 10.4 ASIA-PACIFIC ............................................................................................................................................................... 96 10.4.1 CHINA ............................................................................................................................................................ 99 10.4.2 INDIA ............................................................................................................................................................. 100 10.4.3 JAPAN ........................................................................................................................................................... 102 10.4.4 SOUTH KOREA ................................................................................................................................................ 103 10.4.5 MALAYSIA ..................................................................................................................................................... 104 10.4.6 THAILAND ...................................................................................................................................................... 106 10.4.7 INDONESIA ..................................................................................................................................................... 107 10.4.8 REST OF ASIA-PACIFIC ................................................................................................................................... 108 10.5 SOUTH AMERICA ....................................................................................................................................................... 110 10.5.1 BRAZIL ........................................................................................................................................................... 113 10.5.2 MEXICO ......................................................................................................................................................... 114 10.5.3 ARGENTINA ................................................................................................................................................... 116 10.5.4 REST OF SOUTH AMERICA .............................................................................................................................. 117 10.6 MIDDLE EAST AND AFRICA .................................................................................................................................... 119 10.6.1 GCC COUNTRIES............................................................................................................................................. 122 10.6.2 SOUTH AFRICA ............................................................................................................................................... 123 10.6.3 REST OF MIDDLE EAST AND AFRICA ................................................................................................................ 125 11 COMPETITIVE LANDSCAPE ........................................................................................................ 128 11.1 INTRODUCTION ........................................................................................................................................................... 128 11.2 COMPANY MARKET SHARE ANALYSIS, 2024 (VALUE) ............................................................................... 128 11.3 COMPETITOR DASHBOARD..................................................................................................................................... 129 11.4 PUBLIC PLAYERS STOCK SUMMARY ................................................................................................................. 130 11.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANCIAL .............................................................................. 130 11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES ............................................................................................ 130 11.6.1 DONATION ..................................................................................................................................................... 130 11.6.2 AGREEMENT .................................................................................................................................................. 131 12 COMPANY PROFILES .................................................................................................................. 132 12.1 ANGIODYNAMICS, INC. ............................................................................................................................................. 132 12.1.1 COMPANY OVERVIEW ..................................................................................................................................... 132 12.1.2 FINANCIAL OVERVIEW .................................................................................................................................... 133 12.1.3 PRODUCTS/SOLUTIONS/SERVICES OFFERED ................................................................................................... 134 12.1.4 KEY DEVELOPMENTS ...................................................................................................................................... 135 12.1.5 SWOT ANALYSIS ............................................................................................................................................ 136 12.1.6 KEY STRATEGIES ............................................................................................................................................ 136 12.2 B. BRAUN MELSUNGEN AG .................................................................................................................................... 137 12.2.1 COMPANY OVERVIEW ..................................................................................................................................... 137 12.2.2 FINANCIAL OVERVIEW .................................................................................................................................... 138 12.2.3 PRODUCTS/SOLUTIONS/SERVICES OFFERED ................................................................................................... 138 12.2.4 KEY DEVELOPMENTS ...................................................................................................................................... 139 12.2.5 SWOT ANALYSIS ............................................................................................................................................ 139 12.2.6 KEY STRATEGIES ............................................................................................................................................ 139 12.3 BECTON, DICKINSON AND COMPANY (BD) ....................................................................................................... 140 12.3.1 COMPANY OVERVIEW ..................................................................................................................................... 140 12.3.2 FINANCIAL OVERVIEW .................................................................................................................................... 141 12.3.3 PRODUCTS/SOLUTIONS/SERVICES OFFERED ................................................................................................... 141 12.3.4 KEY DEVELOPMENTS ...................................................................................................................................... 142 12.3.5 SWOT ANALYSIS ............................................................................................................................................ 142 12.3.6 KEY STRATEGIES ............................................................................................................................................ 143 12.4 COOK MEDICAL LLC ................................................................................................................................................... 144 12.4.1 COMPANY OVERVIEW ..................................................................................................................................... 144 12.4.2 FINANCIAL OVERVIEW .................................................................................................................................... 144 12.4.3 PRODUCTS/SOLUTIONS/SERVICES OFFERED ................................................................................................... 145 12.4.4 KEY DEVELOPMENTS ...................................................................................................................................... 145 12.4.5 SWOT ANALYSIS ............................................................................................................................................ 145 12.4.6 KEY STRATEGIES ............................................................................................................................................ 146 12.5 DISTRICLASS MEDICAL SA ..................................................................................................................................... 147 12.5.1 COMPANY OVERVIEW ..................................................................................................................................... 147 12.5.2 FINANCIAL OVERVIEW .................................................................................................................................... 147 12.5.3 PRODUCTS/SOLUTIONS/SERVICES OFFERED ................................................................................................... 147 12.5.4 KEY DEVELOPMENTS ...................................................................................................................................... 147 12.5.5 SWOT ANALYSIS ............................................................................................................................................ 148 12.5.6 KEY STRATEGIES ............................................................................................................................................ 148 12.6 VYGON ............................................................................................................................................................................ 149 12.6.1 COMPANY OVERVIEW ..................................................................................................................................... 149 12.6.2 FINANCIAL OVERVIEW .................................................................................................................................... 150 12.6.3 PRODUCTS/SOLUTIONS/SERVICES OFFERED ................................................................................................... 150 12.6.4 KEY DEVELOPMENTS ...................................................................................................................................... 151 12.6.5 SWOT ANALYSIS ............................................................................................................................................ 151 12.6.6 KEY STRATEGIES ............................................................................................................................................ 152 12.7 SILMAG AG.................................................................................................................................................................... 153 12.7.1 COMPANY OVERVIEW ..................................................................................................................................... 153 12.7.2 FINANCIAL OVERVIEW .................................................................................................................................... 153 12.7.3 PRODUCTS/SOLUTIONS/SERVICES OFFERED ................................................................................................... 153 12.7.4 KEY DEVELOPMENTS ...................................................................................................................................... 153 12.7.5 SWOT ANALYSIS ............................................................................................................................................ 154 12.7.6 KEY STRATEGIES ............................................................................................................................................ 154 12.8 POLY MEDICURE LTD ................................................................................................................................................ 155 12.8.1 COMPANY OVERVIEW ..................................................................................................................................... 155 12.8.2 FINANCIAL OVERVIEW .................................................................................................................................... 156 12.8.3 PRODUCTS/SOLUTIONS/SERVICES OFFERED ................................................................................................... 156 12.8.4 KEY DEVELOPMENTS ...................................................................................................................................... 158 12.8.5 SWOT ANALYSIS ............................................................................................................................................ 158 12.8.6 KEY STRATEGIES ............................................................................................................................................ 159 12.9 PAKUMEDMEDICAL PRODUCTS GMBH ............................................................................................................. 160 12.9.1 COMPANY OVERVIEW ..................................................................................................................................... 160 12.9.2 FINANCIAL OVERVIEW .................................................................................................................................... 160 12.9.3 PRODUCTS/SOLUTIONS/SERVICES OFFERED ................................................................................................... 161 12.9.4 KEY DEVELOPMENTS ...................................................................................................................................... 161 12.9.5 SWOT ANALYSIS ............................................................................................................................................ 162 12.9.6 KEY STRATEGIES ............................................................................................................................................ 162 12.10 SOPHYSA ....................................................................................................................................................................... 163 12.10.1 COMPANY OVERVIEW ..................................................................................................................................... 163 12.10.2 FINANCIAL OVERVIEW .................................................................................................................................... 163 12.10.3 PRODUCTS/SOLUTIONS/SERVICES OFFERED ................................................................................................... 164 12.10.4 KEY DEVELOPMENTS ...................................................................................................................................... 164 12.10.5 SWOT ANALYSIS ............................................................................................................................................ 164 12.10.6 KEY STRATEGIES ............................................................................................................................................ 165 13 DATA CITATIONS ......................................................................................................................... 166

圖表清單 List of Tables & Figures

LIST OF TABLES TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT 40 TABLE 2 GLOBAL IMPLANTABLE PORT MARKET, BY MATERIAL TYPE, 2019–2035 (USD MILLION) 56 TABLE 3 GLOBAL IMPLANTABLE PORT MARKET, FOR SILICONE, BY REGION, 2019–2035 (USD MILLION) 57 TABLE 4 GLOBAL IMPLANTABLE PORT MARKET, FOR POLYURETHANE, BY REGION, 2019–2035 (USD MILLION) 58 TABLE 5 GLOBAL IMPLANTABLE PORT MARKET, FOR TITANIUM, BY REGION, 2019–2035 (USD MILLION) 58 TABLE 6 GLOBAL IMPLANTABLE PORT MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 60 TABLE 7 GLOBAL IMPLANTABLE PORT MARKET, FOR CHEMOTHERAPY, BY REGION, 2019–2035 (USD MILLION) 61 TABLE 8 GLOBAL IMPLANTABLE PORT MARKET, FOR ANTIBIOTIC THERAPY, BY REGION, 2019–2035 (USD MILLION) 62 TABLE 9 GLOBAL IMPLANTABLE PORT MARKET, FOR TOTAL PARENTERAL NUTRITION, BY REGION, 2019–2035 (USD MILLION) 62 TABLE 10 GLOBAL IMPLANTABLE PORT MARKET, FOR BLOOD TRANSFUSION, BY REGION, 2019–2035 (USD MILLION) 63 TABLE 11 GLOBAL IMPLANTABLE PORT MARKET, BY END USER, 2019–2035 (USD MILLION) 65 TABLE 12 GLOBAL IMPLANTABLE PORT MARKET, FOR HOSPITALS, BY REGION, 2019–2035 (USD MILLION) 66 TABLE 13 GLOBAL IMPLANTABLE PORT MARKET, FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2019–2035 (USD MILLION) 67 TABLE 14 GLOBAL IMPLANTABLE PORT MARKET, FOR SPECIALIZED CLINICS, BY REGION, 2019–2035 (USD MILLION) 67 TABLE 15 GLOBAL IMPLANTABLE PORT MARKET, BY INSERTION METHOD, 2019–2035 (USD MILLION) 69 TABLE 16 GLOBAL IMPLANTABLE PORT MARKET, FOR SURGICAL INSERTION, BY REGION, 2019–2035 (USD MILLION) 70 TABLE 17 GLOBAL IMPLANTABLE PORT MARKET, FOR PERCUTANEOUS INSERTION, BY REGION, 2019–2035 (USD MILLION) 71 TABLE 18 GLOBAL IMPLANTABLE PORT MARKET, BY REGION, 2019–2035 (USD MILLION) 72 TABLE 19 NORTH AMERICA: IMPLANTABLE PORT MARKET, BY COUNTRY, 2019–2035 (USD MILLION) 75 TABLE 20 NORTH AMERICA IMPLANTABLE PORT MARKET, BY MATERIAL TYPE, 2019–2035 (USD MILLION) 75 TABLE 21 NORTH AMERICA IMPLANTABLE PORT MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 76 TABLE 22 NORTH AMERICA IMPLANTABLE PORT MARKET, BY END USER, 2019–2035 (USD MILLION) 76 TABLE 23 NORTH AMERICA IMPLANTABLE PORT MARKET, BY INSERTION METHOD, 2019–2035 (USD MILLION) 76 TABLE 24 US IMPLANTABLE PORT MARKET, BY MATERIAL TYPE, 2019–2035 (USD MILLION) 77 TABLE 25 US IMPLANTABLE PORT MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 77 TABLE 26 US IMPLANTABLE PORT MARKET, BY END USER, 2019–2035 (USD MILLION) 77 TABLE 27 US IMPLANTABLE PORT MARKET, BY INSERTION METHOD, 2019–2035 (USD MILLION) 78 TABLE 28 CANADA IMPLANTABLE PORT MARKET, BY MATERIAL TYPE, 2019–2035 (USD MILLION) 78 TABLE 29 CANADA IMPLANTABLE PORT MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 78 TABLE 30 CANADA IMPLANTABLE PORT MARKET, BY END USER, 2019–2035 (USD MILLION) 79 TABLE 31 CANADA IMPLANTABLE PORT MARKET, BY INSERTION METHOD, 2019–2035 (USD MILLION) 79 TABLE 32 EUROPE IMPLANTABLE PORT MARKET, BY COUNTRY, 2019–2035 (USD MILLION) 80 TABLE 33 EUROPE: IMPLANTABLE PORT MARKET, BY MATERIAL TYPE, 2019–2035 (USD MILLION) 82 TABLE 34 EUROPE: IMPLANTABLE PORT MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 82 TABLE 35 EUROPE: IMPLANTABLE PORT MARKET, BY END USER, 2019–2035 (USD MILLION) 82 TABLE 36 EUROPE: IMPLANTABLE PORT MARKET, BY INSERTION METHOD, 2019–2035 (USD MILLION) 83 TABLE 37 GERMANY: IMPLANTABLE PORT MARKET, BY MATERIAL TYPE, 2019–2035 (USD MILLION) 83 TABLE 38 GERMANY: IMPLANTABLE PORT MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 83 TABLE 39 GERMANY: IMPLANTABLE PORT MARKET, BY END USER, 2019–2035 (USD MILLION) 84 TABLE 40 GERMANY: IMPLANTABLE PORT MARKET, BY INSERTION METHOD, 2019–2035 (USD MILLION) 84 TABLE 44 FRANCE: IMPLANTABLE PORT MARKET, BY INSERTION METHOD, 2019–2035 (USD MILLION) 85 TABLE 45 UK: IMPLANTABLE PORT MARKET, BY MATERIAL TYPE, 2019–2035 (USD MILLION) 86 TABLE 46 UK: IMPLANTABLE PORT MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 86 TABLE 47 UK: IMPLANTABLE PORT MARKET, BY END USER, 2019–2035 (USD MILLION) 87 TABLE 48 UK: IMPLANTABLE PORT MARKET, BY INSERTION METHOD, 2019–2035 (USD MILLION) 87 TABLE 49 ITALY: IMPLANTABLE PORT MARKET, BY MATERIAL TYPE, 2019–2035 (USD MILLION) 88 TABLE 50 ITALY: IMPLANTABLE PORT MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 88 TABLE 51 ITALY: IMPLANTABLE PORT MARKET, BY END USER, 2019–2035 (USD MILLION) 89 TABLE 52 ITALY: IMPLANTABLE PORT MARKET, BY INSERTION METHOD, 2019–2035 (USD MILLION) 89 TABLE 53 SPAIN: IMPLANTABLE PORT MARKET, BY MATERIAL TYPE, 2019–2035 (USD MILLION) 90 TABLE 54 SPAIN: IMPLANTABLE PORT MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 90 TABLE 55 SPAIN: IMPLANTABLE PORT MARKET, BY END USER, 2019–2035 (USD MILLION) 91 TABLE 56 SPAIN: IMPLANTABLE PORT MARKET, BY INSERTION METHOD, 2019–2035 (USD MILLION) 91 TABLE 57 RUSSIA: IMPLANTABLE PORT MARKET, BY MATERIAL TYPE, 2019–2035 (USD MILLION) 92 TABLE 58 RUSSIA: IMPLANTABLE PORT MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 92 TABLE 59 RUSSIA: IMPLANTABLE PORT MARKET, BY END USER, 2019–2035 (USD MILLION) 93 TABLE 60 RUSSIA: IMPLANTABLE PORT MARKET, BY INSERTION METHOD, 2019–2035 (USD MILLION) 93 TABLE 61 REST OF EUROPE: IMPLANTABLE PORT MARKET, BY MATERIAL TYPE, 2019–2035 (USD MILLION) 94 TABLE 62 REST OF EUROPE: IMPLANTABLE PORT MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 94 TABLE 63 REST OF EUROPE: IMPLANTABLE PORT MARKET, BY END USER, 2019–2035 (USD MILLION) 95 TABLE 64 REST OF EUROPE: IMPLANTABLE PORT MARKET, BY INSERTION METHOD, 2019–2035 (USD MILLION) 95 TABLE 65 ASIA-PACIFIC: IMPLANTABLE PORT MARKET, BY COUNTRY, 2019–2035 (USD MILLION) 97 TABLE 66 ASIA-PACIFIC: IMPLANTABLE PORT MARKET, BY MATERIAL TYPE, 2019–2035 (USD MILLION) 98 TABLE 67 ASIA-PACIFIC: IMPLANTABLE PORT MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 98 TABLE 68 ASIA-PACIFIC: IMPLANTABLE PORT MARKET, BY END USER, 2019–2035 (USD MILLION) 98 TABLE 69 ASIA-PACIFIC: IMPLANTABLE PORT MARKET, BY INSERTION METHOD, 2019–2035 (USD MILLION) 99 TABLE 70 CHINA: IMPLANTABLE PORT MARKET, BY MATERIAL TYPE, 2019–2035 (USD MILLION) 99 TABLE 71 CHINA: IMPLANTABLE PORT MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 99 TABLE 72 CHINA: IMPLANTABLE PORT MARKET, BY END USER, 2019–2035 (USD MILLION) 100 TABLE 73 CHINA: IMPLANTABLE PORT MARKET, BY INSERTION METHOD, 2019–2035 (USD MILLION) 100 TABLE 74 INDIA: IMPLANTABLE PORT MARKET, BY MATERIAL TYPE, 2019–2035 (USD MILLION) 100 TABLE 75 INDIA: IMPLANTABLE PORT MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 101 TABLE 76 INDIA: IMPLANTABLE PORT MARKET, BY END USER, 2019–2035 (USD MILLION) 101 TABLE 77 INDIA: IMPLANTABLE PORT MARKET, BY INSERTION METHOD, 2019–2035 (USD MILLION) 101 TABLE 78 JAPAN: IMPLANTABLE PORT MARKET, BY MATERIAL TYPE, 2019–2035 (USD MILLION) 102 TABLE 79 JAPAN: IMPLANTABLE PORT MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 102 TABLE 80 JAPAN: IMPLANTABLE PORT MARKET, BY END USER, 2019–2035 (USD MILLION) 102 TABLE 81 JAPAN: IMPLANTABLE PORT MARKET, BY INSERTION METHOD, 2019–2035 (USD MILLION) 103 TABLE 82 SOUTH KOREA: IMPLANTABLE PORT MARKET, BY MATERIAL TYPE, 2019–2035 (USD MILLION) 103 TABLE 83 SOUTH KOREA: IMPLANTABLE PORT MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 103 TABLE 84 SOUTH KOREA: IMPLANTABLE PORT MARKET, BY END USER, 2019–2035 (USD MILLION) 104 TABLE 85 SOUTH KOREA: IMPLANTABLE PORT MARKET, BY INSERTION METHOD, 2019–2035 (USD MILLION) 104 TABLE 86 MALAYSIA: IMPLANTABLE PORT MARKET, BY MATERIAL TYPE, 2019–2035 (USD MILLION) 104 TABLE 87 MALAYSIA: IMPLANTABLE PORT MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 105 TABLE 88 MALAYSIA: IMPLANTABLE PORT MARKET, BY END USER, 2019–2035 (USD MILLION) 105 TABLE 89 MALAYSIA: IMPLANTABLE PORT MARKET, BY INSERTION METHOD, 2019–2035 (USD MILLION) 105 TABLE 90 THAILAND: IMPLANTABLE PORT MARKET, BY MATERIAL TYPE, 2019–2035 (USD MILLION) 106 TABLE 91 THAILAND: IMPLANTABLE PORT MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 106 TABLE 92 THAILAND: IMPLANTABLE PORT MARKET, BY END USER, 2019–2035 (USD MILLION) 106 TABLE 93 THAILAND: IMPLANTABLE PORT MARKET, BY INSERTION METHOD, 2019–2035 (USD MILLION) 107 TABLE 94 INDONESIA: IMPLANTABLE PORT MARKET, BY MATERIAL TYPE, 2019–2035 (USD MILLION) 107 TABLE 95 INDONESIA: IMPLANTABLE PORT MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 107 TABLE 96 INDONESIA: IMPLANTABLE PORT MARKET, BY END USER, 2019–2035 (USD MILLION) 108 TABLE 97 INDONESIA: IMPLANTABLE PORT MARKET, BY INSERTION METHOD, 2019–2035 (USD MILLION) 108 TABLE 98 REST OF ASIA-PACIFIC: IMPLANTABLE PORT MARKET, BY MATERIAL TYPE, 2019–2035 (USD MILLION) 108 TABLE 99 REST OF ASIA-PACIFIC: IMPLANTABLE PORT MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 109 TABLE 100 REST OF ASIA-PACIFIC: IMPLANTABLE PORT MARKET, BY END USER, 2019–2035 (USD MILLION) 109 TABLE 101 REST OF ASIA-PACIFIC: IMPLANTABLE PORT MARKET, BY INSERTION METHOD, 2019–2035 (USD MILLION) 109 TABLE 102 SOUTH AMERICA: IMPLANTABLE PORT MARKET, BY COUNTRY, 2019–2035 (USD MILLION) 111 TABLE 103 SOUTH AMERICA: IMPLANTABLE PORT MARKET, BY MATERIAL TYPE, 2019–2035 (USD MILLION) 112 TABLE 104 SOUTH AMERICA: IMPLANTABLE PORT MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 112 TABLE 105 SOUTH AMERICA: IMPLANTABLE PORT MARKET, BY END USER, 2019–2035 (USD MILLION) 112 TABLE 106 SOUTH AMERICA: IMPLANTABLE PORT MARKET, BY INSERTION METHOD, 2019–2035 (USD MILLION) 113 TABLE 107 BRAZIL: IMPLANTABLE PORT MARKET, BY MATERIAL TYPE, 2019–2035 (USD MILLION) 113 TABLE 108 BRAZIL: IMPLANTABLE PORT MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 113 TABLE 109 BRAZIL: IMPLANTABLE PORT MARKET, BY END USER, 2019–2035 (USD MILLION) 114 TABLE 110 BRAZIL: IMPLANTABLE PORT MARKET, BY INSERTION METHOD, 2019–2035 (USD MILLION) 114 TABLE 111 MEXICO: IMPLANTABLE PORT MARKET, BY MATERIAL TYPE, 2019–2035 (USD MILLION) 114 TABLE 112 MEXICO: IMPLANTABLE PORT MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 115 TABLE 113 MEXICO: IMPLANTABLE PORT MARKET, BY END USER, 2019–2035 (USD MILLION) 115 TABLE 114 MEXICO: IMPLANTABLE PORT MARKET, BY INSERTION METHOD, 2019–2035 (USD MILLION) 115 TABLE 115 ARGENTINA: IMPLANTABLE PORT MARKET, BY MATERIAL TYPE, 2019–2035 (USD MILLION) 116 TABLE 116 ARGENTINA: IMPLANTABLE PORT MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 116 TABLE 117 ARGENTINA: IMPLANTABLE PORT MARKET, BY END USER, 2019–2035 (USD MILLION) 116 TABLE 118 ARGENTINA: IMPLANTABLE PORT MARKET, BY INSERTION METHOD, 2019–2035 (USD MILLION) 117 TABLE 119 REST OF SOUTH AMERICA: IMPLANTABLE PORT MARKET, BY MATERIAL TYPE, 2019–2035 (USD MILLION) 117 TABLE 120 REST OF SOUTH AMERICA: IMPLANTABLE PORT MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 117 TABLE 121 REST OF SOUTH AMERICA: IMPLANTABLE PORT MARKET, BY END USER, 2019–2035 (USD MILLION) 118 TABLE 122 REST OF SOUTH AMERICA: IMPLANTABLE PORT MARKET, BY INSERTION METHOD, 2019–2035 (USD MILLION) 118 TABLE 123 MIDDLE EAST AND AFRICA: IMPLANTABLE PORT MARKET, BY COUNTRY, 2019–2035 (USD MILLION) 120 TABLE 124 MIDDLE EAST AND AFRICA: IMPLANTABLE PORT MARKET, BY MATERIAL TYPE, 2019–2035 (USD MILLION) 121 TABLE 125 MIDDLE EAST AND AFRICA: IMPLANTABLE PORT MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 121 TABLE 126 MIDDLE EAST AND AFRICA: IMPLANTABLE PORT MARKET, BY END USER, 2019–2035 (USD MILLION) 121 TABLE 127 MIDDLE EAST AND AFRICA: IMPLANTABLE PORT MARKET, BY INSERTION METHOD, 2019–2035 (USD MILLION) 122 TABLE 128 GCC COUNTRIES: IMPLANTABLE PORT MARKET, BY MATERIAL TYPE, 2019–2035 (USD MILLION) 122 TABLE 129 GCC COUNTRIES: IMPLANTABLE PORT MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 122 TABLE 130 GCC COUNTRIES: IMPLANTABLE PORT MARKET, BY END USER, 2019–2035 (USD MILLION) 123 TABLE 131 GCC COUNTRIES: IMPLANTABLE PORT MARKET, BY INSERTION METHOD, 2019–2035 (USD MILLION) 123 TABLE 132 SOUTH AFRICA: IMPLANTABLE PORT MARKET, BY MATERIAL TYPE, 2019–2035 (USD MILLION) 123 TABLE 133 SOUTH AFRICA: IMPLANTABLE PORT MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 124 TABLE 134 SOUTH AFRICA: IMPLANTABLE PORT MARKET, BY END USER, 2019–2035 (USD MILLION) 124 TABLE 135 SOUTH AFRICA: IMPLANTABLE PORT MARKET, BY INSERTION METHOD, 2019–2035 (USD MILLION) 124 TABLE 136 REST OF MIDDLE EAST AND AFRICA: IMPLANTABLE PORT MARKET, BY MATERIAL TYPE, 2019–2035 (USD MILLION) 125 TABLE 137 REST OF MIDDLE EAST AND AFRICA: IMPLANTABLE PORT MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 125 TABLE 138 REST OF MIDDLE EAST AND AFRICA: IMPLANTABLE PORT MARKET, BY END USER, 2019–2035 (USD MILLION) 126 TABLE 139 REST OF MIDDLE EAST AND AFRICA: IMPLANTABLE PORT MARKET, BY INSERTION METHOD, 2019–2035 (USD MILLION) 126 TABLE 140 DONATION 130 TABLE 141 AGREEMENT 131 TABLE 142 ANGIODYNAMICS, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 134 TABLE 143 ANGIODYNAMICS, INC.: KEY DEVELOPMENTS 135 TABLE 144 B. BRAUN MELSUNGEN AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED 138 TABLE 145 BECTON, DICKINSON AND COMPANY (BD): PRODUCTS/SOLUTIONS/SERVICES OFFERED 141 TABLE 146 COOK MEDICAL LLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED 145 TABLE 147 DISTRICLASS MEDICAL SA: PRODUCTS/SOLUTIONS/SERVICES OFFERED 147 TABLE 148 VYGON SA: PRODUCTS/SOLUTIONS/SERVICES OFFERED 150 TABLE 149 VYGON SA: KEY DEVELOPMENTS 151 TABLE 150 SILMAG AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED 153 TABLE 151 POLY MEDICURE LTD: PRODUCTS/SOLUTIONS/SERVICES OFFERED 156 TABLE 152 PAKUMEDMEDICAL PRODUCTS GMBH: PRODUCTS/SOLUTIONS/SERVICES OFFERED 161 TABLE 153 SOPHYSA: PRODUCTS/SOLUTIONS/SERVICES OFFERED 164 LIST OF TABLES TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT 40 TABLE 2 GLOBAL IMPLANTABLE PORT MARKET, BY MATERIAL TYPE, 2019–2035 (USD MILLION) 56 TABLE 3 GLOBAL IMPLANTABLE PORT MARKET, FOR SILICONE, BY REGION, 2019–2035 (USD MILLION) 57 TABLE 4 GLOBAL IMPLANTABLE PORT MARKET, FOR POLYURETHANE, BY REGION, 2019–2035 (USD MILLION) 58 TABLE 5 GLOBAL IMPLANTABLE PORT MARKET, FOR TITANIUM, BY REGION, 2019–2035 (USD MILLION) 58 TABLE 6 GLOBAL IMPLANTABLE PORT MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 60 TABLE 7 GLOBAL IMPLANTABLE PORT MARKET, FOR CHEMOTHERAPY, BY REGION, 2019–2035 (USD MILLION) 61 TABLE 8 GLOBAL IMPLANTABLE PORT MARKET, FOR ANTIBIOTIC THERAPY, BY REGION, 2019–2035 (USD MILLION) 62 TABLE 9 GLOBAL IMPLANTABLE PORT MARKET, FOR TOTAL PARENTERAL NUTRITION, BY REGION, 2019–2035 (USD MILLION) 62 TABLE 10 GLOBAL IMPLANTABLE PORT MARKET, FOR BLOOD TRANSFUSION, BY REGION, 2019–2035 (USD MILLION) 63 TABLE 11 GLOBAL IMPLANTABLE PORT MARKET, BY END USER, 2019–2035 (USD MILLION) 65 TABLE 12 GLOBAL IMPLANTABLE PORT MARKET, FOR HOSPITALS, BY REGION, 2019–2035 (USD MILLION) 66 TABLE 13 GLOBAL IMPLANTABLE PORT MARKET, FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2019–2035 (USD MILLION) 67 TABLE 14 GLOBAL IMPLANTABLE PORT MARKET, FOR SPECIALIZED CLINICS, BY REGION, 2019–2035 (USD MILLION) 67 TABLE 15 GLOBAL IMPLANTABLE PORT MARKET, BY INSERTION METHOD, 2019–2035 (USD MILLION) 69 TABLE 16 GLOBAL IMPLANTABLE PORT MARKET, FOR SURGICAL INSERTION, BY REGION, 2019–2035 (USD MILLION) 70 TABLE 17 GLOBAL IMPLANTABLE PORT MARKET, FOR PERCUTANEOUS INSERTION, BY REGION, 2019–2035 (USD MILLION) 71 TABLE 18 GLOBAL IMPLANTABLE PORT MARKET, BY REGION, 2019–2035 (USD MILLION) 72 TABLE 19 NORTH AMERICA: IMPLANTABLE PORT MARKET, BY COUNTRY, 2019–2035 (USD MILLION) 75 TABLE 20 NORTH AMERICA IMPLANTABLE PORT MARKET, BY MATERIAL TYPE, 2019–2035 (USD MILLION) 75 TABLE 21 NORTH AMERICA IMPLANTABLE PORT MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 76 TABLE 22 NORTH AMERICA IMPLANTABLE PORT MARKET, BY END USER, 2019–2035 (USD MILLION) 76 TABLE 23 NORTH AMERICA IMPLANTABLE PORT MARKET, BY INSERTION METHOD, 2019–2035 (USD MILLION) 76 TABLE 24 US IMPLANTABLE PORT MARKET, BY MATERIAL TYPE, 2019–2035 (USD MILLION) 77 TABLE 25 US IMPLANTABLE PORT MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 77 TABLE 26 US IMPLANTABLE PORT MARKET, BY END USER, 2019–2035 (USD MILLION) 77 TABLE 27 US IMPLANTABLE PORT MARKET, BY INSERTION METHOD, 2019–2035 (USD MILLION) 78 TABLE 28 CANADA IMPLANTABLE PORT MARKET, BY MATERIAL TYPE, 2019–2035 (USD MILLION) 78 TABLE 29 CANADA IMPLANTABLE PORT MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 78 TABLE 30 CANADA IMPLANTABLE PORT MARKET, BY END USER, 2019–2035 (USD MILLION) 79 TABLE 31 CANADA IMPLANTABLE PORT MARKET, BY INSERTION METHOD, 2019–2035 (USD MILLION) 79 TABLE 32 EUROPE IMPLANTABLE PORT MARKET, BY COUNTRY, 2019–2035 (USD MILLION) 80 TABLE 33 EUROPE: IMPLANTABLE PORT MARKET, BY MATERIAL TYPE, 2019–2035 (USD MILLION) 82 TABLE 34 EUROPE: IMPLANTABLE PORT MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 82 TABLE 35 EUROPE: IMPLANTABLE PORT MARKET, BY END USER, 2019–2035 (USD MILLION) 82 TABLE 36 EUROPE: IMPLANTABLE PORT MARKET, BY INSERTION METHOD, 2019–2035 (USD MILLION) 83 TABLE 37 GERMANY: IMPLANTABLE PORT MARKET, BY MATERIAL TYPE, 2019–2035 (USD MILLION) 83 TABLE 38 GERMANY: IMPLANTABLE PORT MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 83 TABLE 39 GERMANY: IMPLANTABLE PORT MARKET, BY END USER, 2019–2035 (USD MILLION) 84 TABLE 40 GERMANY: IMPLANTABLE PORT MARKET, BY INSERTION METHOD, 2019–2035 (USD MILLION) 84 TABLE 44 FRANCE: IMPLANTABLE PORT MARKET, BY INSERTION METHOD, 2019–2035 (USD MILLION) 85 TABLE 45 UK: IMPLANTABLE PORT MARKET, BY MATERIAL TYPE, 2019–2035 (USD MILLION) 86 TABLE 46 UK: IMPLANTABLE PORT MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 86 TABLE 47 UK: IMPLANTABLE PORT MARKET, BY END USER, 2019–2035 (USD MILLION) 87 TABLE 48 UK: IMPLANTABLE PORT MARKET, BY INSERTION METHOD, 2019–2035 (USD MILLION) 87 TABLE 49 ITALY: IMPLANTABLE PORT MARKET, BY MATERIAL TYPE, 2019–2035 (USD MILLION) 88 TABLE 50 ITALY: IMPLANTABLE PORT MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 88 TABLE 51 ITALY: IMPLANTABLE PORT MARKET, BY END USER, 2019–2035 (USD MILLION) 89 TABLE 52 ITALY: IMPLANTABLE PORT MARKET, BY INSERTION METHOD, 2019–2035 (USD MILLION) 89 TABLE 53 SPAIN: IMPLANTABLE PORT MARKET, BY MATERIAL TYPE, 2019–2035 (USD MILLION) 90 TABLE 54 SPAIN: IMPLANTABLE PORT MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 90 TABLE 55 SPAIN: IMPLANTABLE PORT MARKET, BY END USER, 2019–2035 (USD MILLION) 91 TABLE 56 SPAIN: IMPLANTABLE PORT MARKET, BY INSERTION METHOD, 2019–2035 (USD MILLION) 91 TABLE 57 RUSSIA: IMPLANTABLE PORT MARKET, BY MATERIAL TYPE, 2019–2035 (USD MILLION) 92 TABLE 58 RUSSIA: IMPLANTABLE PORT MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 92 TABLE 59 RUSSIA: IMPLANTABLE PORT MARKET, BY END USER, 2019–2035 (USD MILLION) 93 TABLE 60 RUSSIA: IMPLANTABLE PORT MARKET, BY INSERTION METHOD, 2019–2035 (USD MILLION) 93 TABLE 61 REST OF EUROPE: IMPLANTABLE PORT MARKET, BY MATERIAL TYPE, 2019–2035 (USD MILLION) 94 TABLE 62 REST OF EUROPE: IMPLANTABLE PORT MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 94 TABLE 63 REST OF EUROPE: IMPLANTABLE PORT MARKET, BY END USER, 2019–2035 (USD MILLION) 95 TABLE 64 REST OF EUROPE: IMPLANTABLE PORT MARKET, BY INSERTION METHOD, 2019–2035 (USD MILLION) 95 TABLE 65 ASIA-PACIFIC: IMPLANTABLE PORT MARKET, BY COUNTRY, 2019–2035 (USD MILLION) 97 TABLE 66 ASIA-PACIFIC: IMPLANTABLE PORT MARKET, BY MATERIAL TYPE, 2019–2035 (USD MILLION) 98 TABLE 67 ASIA-PACIFIC: IMPLANTABLE PORT MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 98 TABLE 68 ASIA-PACIFIC: IMPLANTABLE PORT MARKET, BY END USER, 2019–2035 (USD MILLION) 98 TABLE 69 ASIA-PACIFIC: IMPLANTABLE PORT MARKET, BY INSERTION METHOD, 2019–2035 (USD MILLION) 99 TABLE 70 CHINA: IMPLANTABLE PORT MARKET, BY MATERIAL TYPE, 2019–2035 (USD MILLION) 99 TABLE 71 CHINA: IMPLANTABLE PORT MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 99 TABLE 72 CHINA: IMPLANTABLE PORT MARKET, BY END USER, 2019–2035 (USD MILLION) 100 TABLE 73 CHINA: IMPLANTABLE PORT MARKET, BY INSERTION METHOD, 2019–2035 (USD MILLION) 100 TABLE 74 INDIA: IMPLANTABLE PORT MARKET, BY MATERIAL TYPE, 2019–2035 (USD MILLION) 100 TABLE 75 INDIA: IMPLANTABLE PORT MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 101 TABLE 76 INDIA: IMPLANTABLE PORT MARKET, BY END USER, 2019–2035 (USD MILLION) 101 TABLE 77 INDIA: IMPLANTABLE PORT MARKET, BY INSERTION METHOD, 2019–2035 (USD MILLION) 101 TABLE 78 JAPAN: IMPLANTABLE PORT MARKET, BY MATERIAL TYPE, 2019–2035 (USD MILLION) 102 TABLE 79 JAPAN: IMPLANTABLE PORT MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 102 TABLE 80 JAPAN: IMPLANTABLE PORT MARKET, BY END USER, 2019–2035 (USD MILLION) 102 TABLE 81 JAPAN: IMPLANTABLE PORT MARKET, BY INSERTION METHOD, 2019–2035 (USD MILLION) 103 TABLE 82 SOUTH KOREA: IMPLANTABLE PORT MARKET, BY MATERIAL TYPE, 2019–2035 (USD MILLION) 103 TABLE 83 SOUTH KOREA: IMPLANTABLE PORT MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 103 TABLE 84 SOUTH KOREA: IMPLANTABLE PORT MARKET, BY END USER, 2019–2035 (USD MILLION) 104 TABLE 85 SOUTH KOREA: IMPLANTABLE PORT MARKET, BY INSERTION METHOD, 2019–2035 (USD MILLION) 104 TABLE 86 MALAYSIA: IMPLANTABLE PORT MARKET, BY MATERIAL TYPE, 2019–2035 (USD MILLION) 104 TABLE 87 MALAYSIA: IMPLANTABLE PORT MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 105 TABLE 88 MALAYSIA: IMPLANTABLE PORT MARKET, BY END USER, 2019–2035 (USD MILLION) 105 TABLE 89 MALAYSIA: IMPLANTABLE PORT MARKET, BY INSERTION METHOD, 2019–2035 (USD MILLION) 105 TABLE 90 THAILAND: IMPLANTABLE PORT MARKET, BY MATERIAL TYPE, 2019–2035 (USD MILLION) 106 TABLE 91 THAILAND: IMPLANTABLE PORT MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 106 TABLE 92 THAILAND: IMPLANTABLE PORT MARKET, BY END USER, 2019–2035 (USD MILLION) 106 TABLE 93 THAILAND: IMPLANTABLE PORT MARKET, BY INSERTION METHOD, 2019–2035 (USD MILLION) 107 TABLE 94 INDONESIA: IMPLANTABLE PORT MARKET, BY MATERIAL TYPE, 2019–2035 (USD MILLION) 107 TABLE 95 INDONESIA: IMPLANTABLE PORT MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 107 TABLE 96 INDONESIA: IMPLANTABLE PORT MARKET, BY END USER, 2019–2035 (USD MILLION) 108 TABLE 97 INDONESIA: IMPLANTABLE PORT MARKET, BY INSERTION METHOD, 2019–2035 (USD MILLION) 108 TABLE 98 REST OF ASIA-PACIFIC: IMPLANTABLE PORT MARKET, BY MATERIAL TYPE, 2019–2035 (USD MILLION) 108 TABLE 99 REST OF ASIA-PACIFIC: IMPLANTABLE PORT MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 109 TABLE 100 REST OF ASIA-PACIFIC: IMPLANTABLE PORT MARKET, BY END USER, 2019–2035 (USD MILLION) 109 TABLE 101 REST OF ASIA-PACIFIC: IMPLANTABLE PORT MARKET, BY INSERTION METHOD, 2019–2035 (USD MILLION) 109 TABLE 102 SOUTH AMERICA: IMPLANTABLE PORT MARKET, BY COUNTRY, 2019–2035 (USD MILLION) 111 TABLE 103 SOUTH AMERICA: IMPLANTABLE PORT MARKET, BY MATERIAL TYPE, 2019–2035 (USD MILLION) 112 TABLE 104 SOUTH AMERICA: IMPLANTABLE PORT MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 112 TABLE 105 SOUTH AMERICA: IMPLANTABLE PORT MARKET, BY END USER, 2019–2035 (USD MILLION) 112 TABLE 106 SOUTH AMERICA: IMPLANTABLE PORT MARKET, BY INSERTION METHOD, 2019–2035 (USD MILLION) 113 TABLE 107 BRAZIL: IMPLANTABLE PORT MARKET, BY MATERIAL TYPE, 2019–2035 (USD MILLION) 113 TABLE 108 BRAZIL: IMPLANTABLE PORT MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 113 TABLE 109 BRAZIL: IMPLANTABLE PORT MARKET, BY END USER, 2019–2035 (USD MILLION) 114 TABLE 110 BRAZIL: IMPLANTABLE PORT MARKET, BY INSERTION METHOD, 2019–2035 (USD MILLION) 114 TABLE 111 MEXICO: IMPLANTABLE PORT MARKET, BY MATERIAL TYPE, 2019–2035 (USD MILLION) 114 TABLE 112 MEXICO: IMPLANTABLE PORT MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 115 TABLE 113 MEXICO: IMPLANTABLE PORT MARKET, BY END USER, 2019–2035 (USD MILLION) 115 TABLE 114 MEXICO: IMPLANTABLE PORT MARKET, BY INSERTION METHOD, 2019–2035 (USD MILLION) 115 TABLE 115 ARGENTINA: IMPLANTABLE PORT MARKET, BY MATERIAL TYPE, 2019–2035 (USD MILLION) 116 TABLE 116 ARGENTINA: IMPLANTABLE PORT MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 116 TABLE 117 ARGENTINA: IMPLANTABLE PORT MARKET, BY END USER, 2019–2035 (USD MILLION) 116 TABLE 118 ARGENTINA: IMPLANTABLE PORT MARKET, BY INSERTION METHOD, 2019–2035 (USD MILLION) 117 TABLE 119 REST OF SOUTH AMERICA: IMPLANTABLE PORT MARKET, BY MATERIAL TYPE, 2019–2035 (USD MILLION) 117 TABLE 120 REST OF SOUTH AMERICA: IMPLANTABLE PORT MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 117 TABLE 121 REST OF SOUTH AMERICA: IMPLANTABLE PORT MARKET, BY END USER, 2019–2035 (USD MILLION) 118 TABLE 122 REST OF SOUTH AMERICA: IMPLANTABLE PORT MARKET, BY INSERTION METHOD, 2019–2035 (USD MILLION) 118 TABLE 123 MIDDLE EAST AND AFRICA: IMPLANTABLE PORT MARKET, BY COUNTRY, 2019–2035 (USD MILLION) 120 TABLE 124 MIDDLE EAST AND AFRICA: IMPLANTABLE PORT MARKET, BY MATERIAL TYPE, 2019–2035 (USD MILLION) 121 TABLE 125 MIDDLE EAST AND AFRICA: IMPLANTABLE PORT MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 121 TABLE 126 MIDDLE EAST AND AFRICA: IMPLANTABLE PORT MARKET, BY END USER, 2019–2035 (USD MILLION) 121 TABLE 127 MIDDLE EAST AND AFRICA: IMPLANTABLE PORT MARKET, BY INSERTION METHOD, 2019–2035 (USD MILLION) 122 TABLE 128 GCC COUNTRIES: IMPLANTABLE PORT MARKET, BY MATERIAL TYPE, 2019–2035 (USD MILLION) 122 TABLE 129 GCC COUNTRIES: IMPLANTABLE PORT MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 122 TABLE 130 GCC COUNTRIES: IMPLANTABLE PORT MARKET, BY END USER, 2019–2035 (USD MILLION) 123 TABLE 131 GCC COUNTRIES: IMPLANTABLE PORT MARKET, BY INSERTION METHOD, 2019–2035 (USD MILLION) 123 TABLE 132 SOUTH AFRICA: IMPLANTABLE PORT MARKET, BY MATERIAL TYPE, 2019–2035 (USD MILLION) 123 TABLE 133 SOUTH AFRICA: IMPLANTABLE PORT MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 124 TABLE 134 SOUTH AFRICA: IMPLANTABLE PORT MARKET, BY END USER, 2019–2035 (USD MILLION) 124 TABLE 135 SOUTH AFRICA: IMPLANTABLE PORT MARKET, BY INSERTION METHOD, 2019–2035 (USD MILLION) 124 TABLE 136 REST OF MIDDLE EAST AND AFRICA: IMPLANTABLE PORT MARKET, BY MATERIAL TYPE, 2019–2035 (USD MILLION) 125 TABLE 137 REST OF MIDDLE EAST AND AFRICA: IMPLANTABLE PORT MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 125 TABLE 138 REST OF MIDDLE EAST AND AFRICA: IMPLANTABLE PORT MARKET, BY END USER, 2019–2035 (USD MILLION) 126 TABLE 139 REST OF MIDDLE EAST AND AFRICA: IMPLANTABLE PORT MARKET, BY INSERTION METHOD, 2019–2035 (USD MILLION) 126 TABLE 140 DONATION 130 TABLE 141 AGREEMENT 131 TABLE 142 ANGIODYNAMICS, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 134 TABLE 143 ANGIODYNAMICS, INC.: KEY DEVELOPMENTS 135 TABLE 144 B. BRAUN MELSUNGEN AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED 138 TABLE 145 BECTON, DICKINSON AND COMPANY (BD): PRODUCTS/SOLUTIONS/SERVICES OFFERED 141 TABLE 146 COOK MEDICAL LLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED 145 TABLE 147 DISTRICLASS MEDICAL SA: PRODUCTS/SOLUTIONS/SERVICES OFFERED 147 TABLE 148 VYGON SA: PRODUCTS/SOLUTIONS/SERVICES OFFERED 150 TABLE 149 VYGON SA: KEY DEVELOPMENTS 151 TABLE 150 SILMAG AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED 153 TABLE 151 POLY MEDICURE LTD: PRODUCTS/SOLUTIONS/SERVICES OFFERED 156 TABLE 152 PAKUMEDMEDICAL PRODUCTS GMBH: PRODUCTS/SOLUTIONS/SERVICES OFFERED 161 TABLE 153 SOPHYSA: PRODUCTS/SOLUTIONS/SERVICES OFFERED 164 FIGURE 23 NORTH AMERICA: IMPLANTABLE PORT MARKET SHARE (%), BY COUNTRY, 2024 75 FIGURE 24 EUROPE MARKET ANALYSIS: IMPLANTABLE PORT MARKET, 2019-2035 (USD MILLION) 80 FIGURE 25 EUROPE: IMPLANTABLE PORT MARKET, BY COUNTRY, 2024 & 2035 (USD MILLION) 81 FIGURE 26 EUROPE: IMPLANTABLE PORT MARKET SHARE (%), BY COUNTRY, 2024 81 FIGURE 27 ASIA-PACIFIC MARKET ANALYSIS: IMPLANTABLE PORT MARKET, 2019-2035 (USD MILLION) 96 FIGURE 28 ASIA-PACIFIC: IMPLANTABLE PORT MARKET SHARE, BY COUNTRY, 2024 & 2035 (USD MILLION) 96 FIGURE 29 ASIA-PACIFIC: IMPLANTABLE PORT MARKET SHARE, BY COUNTRY, 2024 (%) 97 FIGURE 30 SOUTH AMERICA MARKET ANALYSIS: IMPLANTABLE PORT MARKET, 2019-2035 (USD MILLION) 110 FIGURE 31 SOUTH AMERICA: IMPLANTABLE PORT MARKET SHARE, BY COUNTRY, 2024 & 2035 (USD MILLION) 110 FIGURE 32 SOUTH AMERICA: IMPLANTABLE PORT MARKET SHARE, BY COUNTRY, 2024 (%) 111 FIGURE 33 MIDDLE EAST & AFRICA MARKET ANALYSIS: IMPLANTABLE PORT MARKET, 2019-2035 (USD MILLION) 119 FIGURE 34 MIDDLE EAST AND AFRICA: IMPLANTABLE PORT MARKET SHARE, BY COUNTRY, 2024 & 2035 (USD MILLION) 119 FIGURE 35 MIDDLE EAST AND AFRICA: IMPLANTABLE PORT MARKET SHARE, BY COUNTRY, 2024 (%) 120 FIGURE 36 GLOBAL IMPLANTABLE PORT MARKET PLAYERS: COMPETITIVE ANALSIS, 2024 (USD MILLION) (% SHARE) 128 FIGURE 37 COMPETITOR DASHBOARD: IMPLANTABLE PORT MARKET 129 FIGURE 38 ANGIODYNAMICS, INC.: FINANCIAL OVERVIEW SNAPSHOT 133 FIGURE 39 ANGIODYNAMICS, INC.: SWOT ANALYSIS 136 FIGURE 40 B. BRAUN MELSUNGEN AG: FINANCIAL OVERVIEW SNAPSHOT 138 FIGURE 41 B. BRAUN MELSUNGEN AG: SWOT ANALYSIS 139 FIGURE 42 BECTON, DICKINSON AND COMPANY (BD): FINANCIAL OVERVIEW SNAPSHOT 141 FIGURE 43 BECTON, DICKINSON AND COMPANY (BD): SWOT ANALYSIS 142 FIGURE 44 COOK MEDICAL LLC: SWOT ANALYSIS 145 FIGURE 45 DISTRICLASS MEDICAL SA: SWOT ANALYSIS 148 FIGURE 46 VYGON SA: FINANCIAL OVERVIEW SNAPSHOT 150 FIGURE 47 VYGON SA: SWOT ANALYSIS 151 FIGURE 48 SILMAG AG: SWOT ANALYSIS 154 FIGURE 49 POLY MEDICURE LTD: FINANCIAL OVERVIEW SNAPSHOT 156 FIGURE 50 POLY MEDICURE LTD: SWOT ANALYSIS 158 FIGURE 51 PAKUMEDMEDICAL PRODUCTS GMBH: SWOT ANALYSIS 162 FIGURE 52 SOPHYSA: SWOT ANALYSIS 164

Single User Price	$4,950 USD
Multi User Licence (up to 10 users)	$5,950 USD
Enterprisewide Price (Global Site License)	$7,250 USD

授權報價

報告摘要

提及公司

同分類最新報告（醫療器材）